4th Quarter - Report — PRIME POLICY GROUP for ROMARK (2021)

Firm

PRIME POLICY GROUP

Client

ROMARK

Income

$50,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

ARPA, emergency use authorization for COVID-19 therapeutic

Lobbyist	Covered position, as disclosed
MITCHELL VAKERICS	2007-08: Staff Assistant, Rep. Timothy Murphy; 2008-09: Legislative Correspondent/Press Assistant, Rep. Timothy Murphy; 2011-15: Legislative Counsel, Rep. Renee Ellmers; 2015: Legislative Director, Rep. Renee Ellmers
PAUL DUSTIN WEISS	—

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Disaster Planning/Emergencies DIS

ARPA, emergency use authorization for COVID-19 therapeutic

Lobbyist	Covered position, as disclosed
MITCHELL VAKERICS	—
PAUL DUSTIN WEISS	—

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

ARPA, emergency use authorization for COVID-19 therapeutic

Lobbyist	Covered position, as disclosed
MITCHELL VAKERICS	—
PAUL DUSTIN WEISS	—

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.